Navigation Links
Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution

BOSTON, Oct. 2 /PRNewswire/ -- Massachusetts General Hospital (MGH) Cancer Center has purchased four radiation therapy treatment systems from Elekta, including three Elekta Infinity and one Elekta Synergy® S. The order, which includes information management software, will enable the facility to offer patients a complete cancer treatment solution from the company.

The three Infinity systems position MGH to take advantage of Volumetric Modulated Arc Therapy (VMAT), a new radiation therapy technique that allows clinicians to deliver tightly focused radiation treatments in less time. A treatment session typically can be conducted in five minutes or less and delivered with single or multiple arcs depending upon the patients needs.

Elekta Infinity also supports all forms of Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).

MGH also purchased Elekta Synergy S, a state-of-the-art digital linear accelerator with integrated imaging capabilities. The facility will use Elekta Synergy S to perform Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) throughout the body, as well as hypofractionated treatments utilizing IGRT and VMAT.

The four treatment machines also feature the HexaPOD(TM) evo RT system, a vision guided patient positioning platform with six degrees of freedom. Six degrees of freedom means that the system can detect and correct misalignments in patient positioning --making it ideal for the very high accuracy required during critical radiation treatments.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
2. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
3. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
4. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Allegheny General Hospital Performs First Liver Transplant
7. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
8. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
9. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
10. New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
11. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... total global healthcare industry is expected to grow at a ... has the highest projected growth at 12.7%, and ... ), is second with growth projected at 11.5%. ... In 2013-2014, total government funded healthcare was nearly 68%. Federal ... in 2013-2014. In real terms, out of pocket expenditure increased ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology:
(Date:11/25/2015)... OK (PRWEB) , ... November 25, 2015 , ... On ... International training center for the Narconon network, announced the release of a new cutting ... 1966 the Narconon organization has been working with drug- and alcohol-addicted individuals with the ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... 25, 2015 , ... “While riding the bus, I saw a passenger in ... there had to be a convenient and comfortable way to protect them from bad ... individuals to safely travel during cold or inclement weather. In doing so, it ensures ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):